Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-25 @ 6:57 PM
Study NCT ID:
NCT07213804
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-10-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-22
Start Date Type:
ACTUAL
Primary Completion Date:
2028-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-07
First Submit QC Date:
None
Study First Post Date:
2025-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED